{"id":6812,"date":"2020-05-13T17:02:35","date_gmt":"2020-05-14T00:02:35","guid":{"rendered":"https:\/\/depts.washington.edu\/pandemicalliance\/?p=6812"},"modified":"2021-03-17T17:03:28","modified_gmt":"2021-03-18T00:03:28","slug":"treatment-of-covid-19-patients-with-convalescent-plasma-in-houston-texas","status":"publish","type":"post","link":"https:\/\/depts.washington.edu\/pandemicalliance\/2020\/05\/13\/treatment-of-covid-19-patients-with-convalescent-plasma-in-houston-texas\/","title":{"rendered":"Treatment of COVID-19 Patients with Convalescent Plasma in Houston Texas"},"content":{"rendered":"<ul>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"45\" data-aria-posinset=\"1\" data-aria-level=\"1\"><span data-contrast=\"auto\">Salazar et al. explored the safety of convalescent plasma therapy among 25 patients with severe and\/or life-threatening COVID-19 disease enrolled at the Houston Methodist hospitals. Patients were transfused with convalescent plasma obtained from donors with confirmed SARS-CoV-2 infection\u00a0<\/span><span data-contrast=\"auto\">who\u00a0<\/span><span data-contrast=\"auto\">been symptom free for 14 days.<\/span><span data-ccp-props=\"{&quot;134233279&quot;:true,&quot;201341983&quot;:0,&quot;335559685&quot;:360,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/li>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"45\" data-aria-posinset=\"2\" data-aria-level=\"1\"><span data-contrast=\"auto\">At\u00a0<\/span><span data-contrast=\"auto\">7\u00a0<\/span><span data-contrast=\"auto\">days\u00a0<\/span><span data-contrast=\"auto\">post-transfusion,\u00a0<\/span><span data-contrast=\"auto\">9<\/span><span data-contrast=\"auto\">\u00a0patients had at least a 1-point improvement in clinical scale, and\u00a0<\/span><span data-contrast=\"auto\">7<\/span><span data-contrast=\"auto\">\u00a0of those were discharged. By 14<\/span><span data-contrast=\"auto\">\u00a0days<\/span><span data-contrast=\"auto\">, 19 (76%) patients had at least a 1-point improvement in clinical status and 11 were discharged. No adverse events\u00a0<\/span><span data-contrast=\"auto\">due to\u00a0<\/span><span data-contrast=\"auto\">plasma transfusion were observed.\u00a0<\/span><span data-ccp-props=\"{&quot;134233279&quot;:true,&quot;201341983&quot;:0,&quot;335559685&quot;:360,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/li>\n<\/ul>\n<p><i><span data-contrast=\"none\">Salazar et al. (May 13, 2020). Treatment of COVID-19 Patients with Convalescent Plasma in Houston Texas. Pre-print\u00a0downloaded May 13 from\u00a0<\/span><\/i><a href=\"https:\/\/doi.org\/10.1101\/2020.05.08.20095471\"><span data-contrast=\"none\">https:\/\/doi.org\/10.1101\/2020.05.08.20095471<\/span><\/a><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559685&quot;:720,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Salazar et al. explored the safety of convalescent plasma therapy among 25 patients with severe and\/or life-threatening COVID-19 disease enrolled at the Houston Methodist hospitals. Patients were transfused with convalescent plasma obtained from donors with confirmed SARS-CoV-2 infection\u00a0who\u00a0been symptom free for 14 days.\u00a0 At\u00a07\u00a0days\u00a0post-transfusion,\u00a09\u00a0patients had at least a 1-point improvement in clinical scale, and\u00a07\u00a0of those&#8230;<\/p>\n<div><a class=\"more\" href=\"https:\/\/depts.washington.edu\/pandemicalliance\/2020\/05\/13\/treatment-of-covid-19-patients-with-convalescent-plasma-in-houston-texas\/\">Read more<\/a><\/div>\n","protected":false},"author":8,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[6],"tags":[],"topic":[19],"class_list":["post-6812","post","type-post","status-publish","format-standard","hentry","category-article-summary","topic-testing-and-treatment"],"_links":{"self":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/6812","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/comments?post=6812"}],"version-history":[{"count":1,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/6812\/revisions"}],"predecessor-version":[{"id":6813,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/6812\/revisions\/6813"}],"wp:attachment":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/media?parent=6812"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/categories?post=6812"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/tags?post=6812"},{"taxonomy":"topic","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/topic?post=6812"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}